Brolucizumab—early real-world experience: BREW study

被引：0
|
作者：
Ashish Sharma
Nilesh Kumar
Nikulaa Parachuri
Srinivas R. Sadda
Giulia Corradetti
Jeffrey Heier
Adam T. Chin
David Boyer
Pouya Dayani
Sruthi Arepalli
Peter Kaiser
机构：
[1] Lotus Eye Hospital and Institute,
[2] Doheny Eye Institute Los Angeles CA USA,undefined
[3] Department of Ophthalmology David Geffen School of Medicine,undefined
[4] UCLA,undefined
[5] Ophthalmic Consultants of Boston,undefined
[6] Tufts Medical Center,undefined
[7] Retina Vitreous Associates Medical Group,undefined
[8] Cole Eye Institute,undefined
[9] Cleveland Clinic,undefined
来源：
Eye | 2021年 / 35卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1045 / 1047
页数：2
相关论文
共 50 条
  • [21] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [22] Early Experience and Patient Characteristics from Opera: A Real-World Study of Pegcetacoplan Treatment
    Fishman, Jesse
    Min, Jinny
    Guarinoni, Joseph
    Lin, Katherine
    BLOOD, 2022, 140 : 11441 - 11442
  • [23] Real-World Experience with Ofatumumab
    Thomas, K.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 202 - 203
  • [24] Ocrelizumab real-world experience
    Moss, B.
    Utigard, E.
    Baldassari, L.
    Cohen, J.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 504 - 505
  • [25] Real-world experience of apremilast
    Fremlin, G. A.
    Bedlow, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 : 63 - 63
  • [26] Real-world experience - Reply
    Hutchinson, D
    CHEMICAL ENGINEERING PROGRESS, 1998, 94 (03) : 8 - 8
  • [27] Real-World Experience with Ocrelizumab
    Moss, Brandon P.
    Utigard, Erica
    Baldassari, Laura E.
    Cohen, Jeffrey A.
    Ontaneda, Daniel D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 69 - 70
  • [28] Real-world experience with ocrelizumab
    Moss, B.
    Parrotta, E.
    Baldassari, L.
    Planchon, S.
    Cohen, J.
    Ontaneda, D.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 780 - 781
  • [29] Real-World Experience with Ocrelizumab
    Moss, Brandon
    Parrotta, Erica
    Baldassari, Laura
    Cohen, Jeffrey
    Ontaneda, Daniel
    NEUROLOGY, 2019, 92 (15)
  • [30] REAL-WORLD EXPERIENCE IN CHEMISTRY
    MELTON, LA
    SCIENCE, 1994, 266 (5183) : 203 - 204
12345